Website Search
ID 15650

David Goeddel (1986)

Description:
David Goeddel had a problem: how to synthesize human insulin? His relentless energy and tenacity pushed the insulin project to success. Goeddel relaxes by going mountain-climbing.
Keywords:
human insulin,relentless energy,tenacity,david goeddel
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

15088. Gilbert's approach to synthesizing insulin, David Goeddel
David Goeddel talks about how another group was trying to make insulin.
15087. Genentech's approach to making insulin, David Goeddel
David Goeddel was one of the first scientists Herb Boyer hired for the insulin project. Here, David Goeddel talks about Genentech's general strategy for synthesizing insulin.
16118. Recombinant DNA, David Goeddel
David Goeddel talks about recombinant DNA.
15085. Fierce competition to synthesize insulin, David Goeddel
David Goeddel talks about the other groups working on the insulin problem.
15084. First steps toward making insulin, David Goeddel
David Goeddel talks about what it was like to work at Genetech during its early days.
15086. Synthesizing DNA, David Goeddel
David Goeddel talks about the strategy Genentech used in making synthetic insulin.
15089. Stock in Genentech, David Goeddel
In 1980, Genentech became the first publicly traded biotech company. David Goeddel talks about his investment.
15927. Isolating DNA to make human insulin
Walter Gilbert's group tried to isolate the human insulin DNA sequence using the rat insulin DNA sequence.
15928. How insulin is made using bacteria
Synthetic human insulin was the first golden molecule of the biotech industry and the direct result of recombinant DNA technology. Currently, millions of diabetics worldwide use synthetic insulin to regulate their blood sugar levels. Synthetic insulin i
15929. How insulin is made using yeast
Synthetic human insulin was the first golden molecule of the biotech industry and the direct result of recombinant DNA technology. Currently, millions of diabetics worldwide use synthetic insulin to regulate their blood sugar levels. Synthetic insulin i
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationPublic EventsNewsstandPartner With UsGiving